MBOT vs. SMLR, NNOX, STIM, SMTI, ZIMV, RCEL, SNWV, NVRO, NYXH, and ELMD
Should you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include Semler Scientific (SMLR), Nano-X Imaging (NNOX), Neuronetics (STIM), Sanara MedTech (SMTI), ZimVie (ZIMV), AVITA Medical (RCEL), SANUWAVE Health (SNWV), Nevro (NVRO), Nyxoah (NYXH), and Electromed (ELMD). These companies are all part of the "medical equipment" industry.
Microbot Medical vs.
Microbot Medical (NASDAQ:MBOT) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, community ranking, profitability and institutional ownership.
Microbot Medical presently has a consensus price target of $9.00, indicating a potential upside of 264.37%. Semler Scientific has a consensus price target of $71.00, indicating a potential upside of 119.61%. Given Microbot Medical's higher probable upside, equities research analysts clearly believe Microbot Medical is more favorable than Semler Scientific.
Semler Scientific has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.
In the previous week, Semler Scientific had 6 more articles in the media than Microbot Medical. MarketBeat recorded 9 mentions for Semler Scientific and 3 mentions for Microbot Medical. Semler Scientific's average media sentiment score of 0.89 beat Microbot Medical's score of 0.77 indicating that Semler Scientific is being referred to more favorably in the news media.
Microbot Medical has a beta of 1.4, indicating that its stock price is 40% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.29, indicating that its stock price is 29% more volatile than the S&P 500.
Microbot Medical received 347 more outperform votes than Semler Scientific when rated by MarketBeat users. Likewise, 70.79% of users gave Microbot Medical an outperform vote while only 66.67% of users gave Semler Scientific an outperform vote.
Semler Scientific has a net margin of 72.65% compared to Microbot Medical's net margin of 0.00%. Semler Scientific's return on equity of 50.77% beat Microbot Medical's return on equity.
16.3% of Microbot Medical shares are owned by institutional investors. Comparatively, 49.4% of Semler Scientific shares are owned by institutional investors. 5.4% of Microbot Medical shares are owned by insiders. Comparatively, 30.2% of Semler Scientific shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
Semler Scientific beats Microbot Medical on 11 of the 15 factors compared between the two stocks.
Get Microbot Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Microbot Medical Competitors List
Related Companies and Tools
This page (NASDAQ:MBOT) was last updated on 5/1/2025 by MarketBeat.com Staff
